Watch experts from PHAR, Novartis, and Bausch Health discuss the Delphi panels and how the results are used.

For over 15 years, PHAR has conducted RAND/UCLA modified Delphi panels to obtain consensus among clinicians. During this webinar, the experts will broadly present different methods for gaining consensus including the different “Delphi panel” approaches that exist, the history of the method used, the behavioral science behind why these panels work, how these panels (both in person and virtually) are conducted, and the outcome of the panels.

In addition to Dr. Michael Broder, President of PHAR’s, experience, there are two researchers (one physician and one research scientist) from the pharmaceutical industry who share their experience participating in these panels. They provide their perspective on leading these panels (including why sometimes it’s recommended they are blinded to all aspects), their experience participating in the discussions, and how they have used the results.

Key Topics Include:

  • Overview of the different ways to obtain consensus from expert clinicians
  • The broad steps involved in conducting a RAND/UCLA modified Delphi panel method
  • The possible outcomes of such a panel
  • Benefits and challenges of this method
Click to watch the webinar recording. To view the presentation full screen simply click the square icon located in the bottom-right corner of the video-viewer.

Resources

To retrieve a PDF copy of the presentation, click on the link below the slide player. From this page, click on the “Download” link to retrieve the file.

Presenters

Executive Medical Director and Team Lead for Non-Malignant Hematology
US Oncology Medical
Novartis Pharmaceuticals Corporation

As part of her role at Novartis Oncology, Dr. Jincy Paulose and her team have conducted several Delphi panels in sickle cell disease (SCD) which includes work with NYC emergency room doctors to help create consensus guidelines for helping patients with SCD. She has over 10 years experience in various positions in the pharmaceutical industry.

Vice President
Health Economics & Outcomes Research
Bausch Health

George Joseph has experience using the modified Delphi method to develop clinical guidelines in hematology. He has over 20 years of experience in HEOR and previously worked at Novartis Oncology, Sanofi, and Amgen. George has a PhD in Health Services from UCLA, an MS from the University of Georgia, and a BPharm from the University of Mumbai.

President
Partnership for Health Analytic Research (PHAR)

Dr. Michael Broder has 30 years' experience in health economic and outcomes research. He has conducted dozens of expert panels on a wide variety of topics. In addition to being an experienced health services researcher, he is a board-certified physician and provides clinical expertise for many studies at PHAR.

Production Partner

Partnership for Health Analytic Research (PHAR)

PHAR brings together experienced methodologists and trained clinicians to produce high-quality real-world evidence that unlocks the hidden value of our clients’ innovative products.

Additional Content From Partnership for Health Analytic Research (PHAR)

Additional Content From HealthEconomics.Com

Social Media Data: Opportunities and Insights for Clinical Research

Social Media Data: Opportunities and Insights for Clinical Research

Hear four experts from ICON and Kap Code provide insights on how to collect, use, analyze, and interpret social media data in different contexts. These experts share knowledge from over fifteen years of successfully developing and adapting algorithms to treat this kind of data.

Related Content